Skip to main content
Home
Shalina

Main navigation

  • Home
User account menu
  • Log in

Download in App

Breadcrumb

  1. Home
Unique Code
1000

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.

Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3.

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.

Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.

Paediatricians provide higher quality care to children and adolescents in primary care: A systematic review.

Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.

Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.

The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention.

Applying Pharmacogenomic Guidelines to Combat Medical Care.

Determinants of clinical practice guidelines' utilization for the management of musculoskeletal disorders: a scoping review.

Pagination

  • Previous page
  • 2
  • Next page
Download in App
RSS feed
Powered by Drupal